ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SCYX vs JNJ // NET PROFIT MARGIN

SCYNEXIS Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: SCYX 1 — JNJ 7
▲ NET PROFIT MARGIN LEADER: JNJ
net-margins
-41.80%
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCYX VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SCYX JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 25.50% -60.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -13.76% 2.97% -16.73 JNJ /fcf-yield <GO>
Operating Margin -60.00% 34.70% -94.70 JNJ /operating-margins <GO>
Net Profit Margin ACTIVE -41.80% 28.50% -70.30 JNJ /net-margins <GO>
Revenue Growth (YoY) 180.00% 6.00% +174.00 SCYX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 8/9 -4.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.7 62.1 -24.40 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $38.4M $662.49B -$662.45B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SCYX REV JNJ REV SCYX GROSS % JNJ GROSS % SCYX FCF JNJ FCF
FY 2025 $20.6M $94.19B — 67.9% -$5.3M $19.70B
FY 2024 $3.7M $88.82B — 69.1% -$24.0M $19.84B
FY 2023 $140.1M $85.16B — — $60.2M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCYX // BETA —
JNJ // BETA 1.08